Clinical Trial Update: A Multi-site Expanded Access Program for MDMA-assisted Psychotherapy for Patients With Treatment-resistant PTSD

View source ↗

Summary

Expanded access program of MDMA-assisted psychotherapy for treatment-resistant PTSD across multiple sites is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Lykos Therapeutics | Conditions: Post Traumatic Stress Disorder | Status: NO_LONGER_AVAILABLE